Oral Cladribine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral Cladribine, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]